RT @uptoTate: Have you heard of nipocalimab? It prevents IgG-FcRn by binding to the FcRn IgG binding site. This is one t
Tweet Content
Have you heard of nipocalimab? It prevents IgG-FcRn by binding to the FcRn IgG binding site. This is one to watch in our diseases (RA, Sjogren’s, SLE, myopathies.) Dr. Postolova #RWCS23 @RheumNow @RWCSmtg https://t.co/qMGA6IdtUE
Show on Archive Page
On
Display in Search Results
On
PDQ
Off